Preview

Epilepsy and paroxysmal conditions

Advanced search

ПЕРАМПАНЕЛ: ФАРМАКОКИНЕТИКА И ЛЕКАРСТВЕННЫЕ ВЗАИМОДЕЙСТВИЯ

Full Text:

Abstract

.

About the Author

Ф. Патсалос
Лондонский Институт неврологии
United Kingdom


References

1. Fuseau E., Templeton D., Hussein Z. Population Pharmacokinetics and Pharmacodynamics of Perampanel in Patients with Refractory Partial Seizures. Epilepsy Currents. 2011; 11 (1): Abs 1.264.

2. Hussein Z., Critchley D., Ferry J., Laurenza A. Population Pharmacokinetics of Perampanel, a Selective, Non-competitive AMPA Receptor Antagonist, in Patients with Refractory Partial Onset Seizures Participating in a Randomized, Double-blind, Placebo-controlled Phase III Study. Epilepsia. 2011; 52 (6): 248-9.

3. Laurenza A., Ferry J., Hussein Z. Population Pharmacokinetics and Pharmacodynamics of Perampanel: APooled Analysis From Three Phase III Trials. Epilepsy Currents. 2012; 12 (1): 216-7.

4. Patsalos P.N. Drug Interactions With the Newer Antiepileptic Drugs (AEDs) – Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs. Clinical Pharmacokinetics. 2013a; 52: 927-966.

5. Patsalos P.N. Drug Interactions with the Newer antiepileptic drugs (AEDs) – Part 2: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs and Drugs Used to Treat Non-epilepsy Disorders. Clinical Pharmacokinetics. 2013b; 52: 1045-1061.

6. Инструкция по медицинскому применению прапарата Файкомпа РУ ЛП 002200 от 23.08.2013.


For citation:


. . Epilepsy and paroxysmal conditions. 2014;6(5):16-18. (In Russ.)

Views: 106


ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)